Page URL:

Genetic variants linked to severe COVID-19 identified

14 December 2020
Appeared in BioNews 1076

Five genes associated with the development of critical illness in patients with COVID-19 have been identified.

Researchers led by Dr Kenneth Baillie, academic consultant in critical care medicine, Roslin Institute, University of Edinburgh, performed a genome-wide association study on 2244 critically ill patients with COVID-19 from 208 UK intensive care units, which represents more than 95 percent of all intensive care beds. They compared the genetic make-up of these patients to a control group, and identified five genetic sequences that were more common in those patients who became critically ill with COVID-19. These genetic sequences all relate to genes that are involved in inflammatory processes and the body's response to viruses.

Dr Kenneth Baillie explained 'The really exciting thing about this study is that we have found genes that are directly therapeutically relevant, so they lead us directly to treatments.'

The global collaborative study was intended to understand the genetics underlying susceptibility to life-threatening illness, but also to understand new infections like COVID-19.

Scientists have known for many years that variation in susceptibility to infection is strongly genetic. Hence, looking into the genome is a good place to investigate the complexity of the immune system.

COVID-19 is an inflammatory condition, and for the purpose of this study, only patients were included who had severe inflammatory lung disease, caused by COVID-19, and who were in the ICU with a ventilator breathing for them.

Published recently in Nature, the scientists found crucial differences in the genes IFNAR2, TYK2, OAS1, DPP9 and CCR2.

Of the gene mutations the researchers discovered, the most clinically relevant is TYK2 (tyrosine kinase 2), which is a signalling molecule associated with multiple different pathways that promote inflammation. The scientists performed computational analysis on the genetic variant that changes the amount of TYK2 that your body produces and discovered that people who produce more TYK2 are more susceptible to severe COVID-19. Dr Baillie suggests inhibiting the TYK2 enzyme as a treatment for severe COVID-19.

Importantly, a class of drugs, called JAK inhibitors, inhibit TYK2 and are already approved for medical use. Baricitinib is one such drug that is used in the treatment of rheumatoid arthritis, and now baricitinib is undergoing clinical trials for use in the treatment of COVID-19.

Similarly, a drug called phosphoesterase 12 inhibitor targets the OAS1 (oligoisoadenylate synthetase 1) gene, which promotes the signalling through the anti-viral pathways that these genes initiate and creates an enzyme that degrade viral RNAs.

Furthermore, the scientists propose that increasing the activity of the gene INFAR2 (interferon-α/β receptor 2) could create protection to COVID-19 in the early stages of disease, which they believe may mimic the effect of interferon treatment, which triggers the immune system to defend against viruses.

Overall, the findings suggest that severe COVID-19 is the result of at least two biological mechanisms: innate antiviral defences, which are known to be important early in the disease, and host-driven inflammatory processes, which are a key feature of late, life-threatening COVID-19. The evidence strongly supports the urgent need for large-scale clinical trials to assess the use of drugs targeting the genes involved in the treatment of COVID-19.

Dr Baillie said: 'What our study does is find a much stronger signal, it is by far the strongest genetic signal of any of the studies that have been seen and by far the largest study of its type that is looking at patients with critical illness'.

The team are continuing their efforts with the aim to whole genome sequence 35,000 people. For every patient, they need to find a match who had COVID-19 but did not require hospital treatment. To register for this trial please visit here.

COVID: Genes hold clues to why some people get severely ill
BBC News |  11 December 2020
Gene discovery points to new COVID-19 treatments
The University of Edinburgh |  11 December 2020
Genetic mechanisms of critical illness in COVID-19
Nature |  11 December 2020
How your genes can make COVID more deadly
The Telegraph |  11 December 2020
The five genes that make you more likely to die from coronavirus or be admitted to intensive care
Daily Mail |  11 December 2020
The five genes that may make you more likely to die from COVID-19
Evening Standard |  11 December 2020
11 October 2021 - by Semyon Bodian 
A gene variant has been identified that is linked to the development of both Alzheimer's and severe COVID-19, new research has found...
4 October 2021 - by Dr Melanie Krause 
Individuals with a specific version of the OAS1 gene have natural antiviral defences against SARS-CoV-2, resulting in less severe COVID-19 disease...
12 July 2021 - by Abbie Harper 
Our genomes can influence the susceptibility and response to SARS-CoV-2 infection, determining the severity of symptoms...
17 May 2021 - by Elpida Fragouli 
Genomic sequencing has numerous applications, including determining genealogy, the presence or absence of common mutations in a couple who are considering becoming pregnant, and even the susceptibility of contracting SARS-CoV-2, the virus which leads to COVID-19, and the severity of the subsequent disease...
11 January 2021 - by Dr Melanie Krause 
Stem cells from umbilical cords may help treat severe COVID-19 according to a small study from the University of Miami, Florida...
16 November 2020 - by Anna Wernick 
The discovery of a hidden gene in the SARS-CoV-2 virus could offer new clues to combatting COVID-19...
5 October 2020 - by Emma Bunting 
A stretch of DNA, thought to triple the risk of developing severe COVID-19, has been passed down by Neanderthals to modern humans, scientists claim...
28 September 2020 - by Dr Melanie Krause 
Two new studies highlight the underlying genetic causes that begin to explain why some COVID-19 patients suffer worse symptoms than others....
15 June 2020 - by Dr Molly Godfrey 
An association between patient blood type and severity of COVID-19 symptoms has been detected in preliminary studies...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.